Atlas Trials

Single Dose and Multiple Dose Safety, Tolerability, PK,and Food Effect Study,and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects

Clinical trial NCT04982913 · COMPLETED

Trial details

NCT number
NCT04982913
Sponsor
Sunshine Lake Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza
Start date
2021-08-24
Primary completion
2022-10-02
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.